Another Commercial Assault (the Pharmaceutical Carnage – Patent ‘738)
Ed. note: Some background…
Mortimer David Sackler was an American psychiatrist and entrepreneur (psychiatry and drugs “killing the logos“: the “Jewish mission to heal the world”) who was a co-owner, with his brother Raymond Sackler, of Purdue Pharma. Mortimer Sackler was the second son of Jewish immigrant Isaac Sackler, who was born in what is now Ukraine. Raymond Sackler was also an American physician, billionaire entrepreneur, and philanthropist (that’s the standard oligarchical model). Purdue Pharma is the developer of OxyContin. Richard Stephen Sackler is an American billionaire (Jewish oligarchs) businessman, and a former chairman and president of Purdue Pharma. Richard Sackler’s father was Raymond Sackler. Richard Sackler became head of research and development and head of marketing for OxyContin.
There is as to be expected controversy surrounding Sackler’s “philanthropy”. It is difficult coming across real time information on the Sackler family philanthropy but Inside Philanthropy is a good start. OxyContin has generated $35 billion for the Sackler family. Does that qualify them as Jewish oligarchs? Of course all the “respectable” media sources now reporting on OxyContin being an “addictive opioid-based weapon of mass pharmaceutical destruction”, will omit “Jewish” in their coverage. So the carnage continues.
In 2016, Purdue Pharma’s product OxyContin was the 54th most prescribed medication in the United States with more than 14 million prescriptions at a value of $35-billion (U.S.) between Canada and the United States since the mid-1990s. The product OxyContin is highly addictive and has been extremely profitable. Addiction and death from opioid abuse has skyrocketed since the 1990s when OxyContin was first introduced. Some of the abuse comes from opioid abusers crushing the pills into a powder then melting the powder to inject themselves. Purdue Pharma then came up with an alternative known as OxyNeo which it was claimed causes less addiction. OxyNeo was timed for release when Patent ‘738 expired. This was claimed to prevent competition from generic drug manufacturers like Canada’s Apotex Inc. Purdue pulled OxyContin from the market in 2012 when the patent expired. A host of other, stronger drugs filled the void, including illicit fentanyl for pain relief.
Bernard Charles “Barry” Sherman, the Canadian businessman and philanthropist who was chairman and CEO of Apotex Inc., was found dead along with his wife, murdered in their home found hung from a pool railing on December 15, 2017. Sherman was considered the 15th wealthiest Canadian with assets valued at $4.77 billion. Sherman was born into a Jewish family in Toronto. Toronto police have not made any arrests and the case is still being investigated. Another high profile ongoing murder investigation until the public forgets about the murders. Sherman’s company Apotex Inc. was developing a generic alternative to Sackler’s Purdue Pharma’s OxyContin product.
Apotex Inc. was one of several companies that applied for approval to market copies of OxyContin. The alternative product would have a “controlled release” designed to deliver an initial dose of the opioid painkiller oxycodone. As the pill dissolves it would deliver the remaining oxycodone gradually over a 12 hour period. Oxycodone is a “chemical cousin” of heroin. Apotex Inc. spent $3 million developing their alternative generic pain killer to Purdue Pharma’s OxyContin. The planning for the release of Apotex’s generic oxycodone product was based on the expiration date of Purdue Pharma’s patent.
Patent 2098738 (Patent ‘738) was filed in Gatineau, Quebec, Canada by the Canadian subsidiary of U.S. drug giant Purdue Pharma in 1992. The following is a brief summary of the patent issued on Purdue Pharma’s OxyContin and the expiration date of the patent.
How many people know for example, the world’s largest generic drug company is the Israeli firm Teva Pharmaceuticals with $23.7 billion in sales in 2017? Teva has a current market capitalization of $49 billion. Teva shares can be purchased on Wall Street and in Israel. Remember the Canadian pharmaceutical firm Apotex when its founder and his wife, Barry and Honey Sherman, showed up dead in their indoor home pool? Apotex is Canada’s biggest pharmaceutical company specializing in generic drugs. It turns out Sherman’s Apotex company was “accused of stealing Teva Pharmaceutical secrets.” The kinds of connections that make you wonder that if you even think about tampering with the profits of Israel-based companies you may want to think twice.
Implications of OxyContin Patent in Canada
Tuesday, November 13, 2012 • by Clair Palmer
Canadian Patent No. 2,098,738 is set to expire on November 25, 2012. This patent is likely unique in the history of Canadian patented medicines in that its expiry is not being hailed as a benefit to the Canadian public by providing for the entry of lower priced generic. Rather, the expiry of this particular patent is being met with grave concern. The reason is Canadian Patent No. 2,098,738 has prevented low cost generic OxyContin from flooding the Canadian market.
There have been numerous articles written by the mainstream press detailing the concerns (links to several are provided below).
OxyContin is a time-release formulation of the highly addictive and powerful pain killer, oxycodone that was voluntary taken off the market in Canada by Purdue Pharma Canada in view of drug abuse concerns. In the Canadian market, OxyContin was replaced by OxyNeo a formulation designed to be more difficult to abuse and misuse by those addicted to the drug. OxyNeo is itself a patented medicine.
Although the expiry of the OxyContin patent is being met with concern, OxyContin’s replacement by OxyNeo has not been without controversy. In particular, critics of OxyNeo have alleged that Purdue Pharma Canada’s move to replace OxyContin with OxyNeo has more to do with the loss of exclusivity in the market that will occur once the ‘738 patent expires and generics [generic like Sherman’s Apotex Inc. spending $3 million developing] enter the market then it does with drug abuse concerns (see link below).
It will be interesting to see if market approval is given to generic OxyContin. Regardless of whether market approval is given to the generics, one can be certain that not everyone will be happy with the decision Health Canada makes.
Investigators looking into the murder of Barry Sherman and his wife will have already collected this evidence, so nothing new is being presented here that is not already known concerning Patent ‘738, opioids and Purdue Pharma’s business model. It is highly unlikely big pharma will self-correct considering the billions of dollars being generated yearly with the promotion and marketing of Oxycodone (OxyContin among other manufacturers) being a “commercial triumph while at the same time a public health tragedy.”
Source: CBS This Morning
Family behind OxyContin maker engineered opioid crisis, Massachusetts AG says
January 24, 2019
The Massachusetts attorney general is targeting Purdue Pharma and eight members of the Sackler family who own the company, alleging in a lawsuit they are “personally responsible” for deceptively selling OxyContin.
The attorney general, Maura Healey, sat down with “CBS This Morning.” She alleges the Sackler family hired “hundreds of workers to carry out their wishes” – pushing doctors to get “more patients on opioids, at higher doses, for longer, than ever before” all while paying “themselves billions of dollars.”
In her lawsuit, Healey names eight members of the family that own Purdue Pharma, alleging they “micromanaged” a “deceptive sales campaign.” In the conclusion to the complaint, Healey said the Sackler family used the power at their disposal to engineer an opioid crisis. Almost 400,000 people died from opioid overdoses between 1999 and 2017, according to the CDC.
Healey said this is the most complete picture to date of how the opioid crisis began, and why the Sackler family itself should be held accountable. “They don’t want to accept blame for this. They blame doctors, they blame prescribers and worst of all, they blame patients,” Healey said.
Purdue Pharma called the accusations “a rush to vilify” the drugmaker. There’s a lot in the lawsuit that’s still redacted, and lawyers for Purdue plan to argue on Friday that it should stay that way.
Healey said Purdue Pharma and the Sackler family are one and the same.
In one alleged instance, then-president Richard Sackler devised what Healey describes as Sackler’s “solution to the overwhelming evidence of overdose and death,” writing in a confidential email, “we have to hammer on the abusers in every way possible. They are the culprits and the problem.”
In a statement, Purdue Pharma said the lawsuit “distorts critical facts” and “cherry-picked from among tens of millions of emails and other business documents.”
To that, Healey said, “If Purdue thinks we’re cherry picking, I invite them to produce all of their documents and let the public judge for itself.”
CBS News reached out to the members of the Sackler family named in the complaint, as well as their lawyer. Three declined comment through a press representative and we never heard back from the rest. But this is a family that rarely addresses its connection to the company that made it rich.
Please go to CBS This Morning to read the entire article.
Further related reading on certain aspects of our human condition:
A Make or Break for America – Unbridled Arrogance – The Genie Is Out of the Bottle – You Cannot Bury the Truth – The Same Root of Evil – Nuclear Blackmail – Extremely Disproportionate Influence – Horrible and Bitter Wine – Compartmentalization: A Composite Work of Evil
If readers want an alternative to opioids for pain relief, CBD oil may be of some help. This isn’t medical advice and is only suggested as an alternative. And be sure to do serious investigation into the companies providing CBD oil. Just like any other industry it is full of substandard hyper-marketed expensive junk.
More on the criminal drug/pharma industry. Robert Kennedy Jr. was among legal teams in an LA lawsuit continuing Feb. 7th,2019 alleging Merck committed fraud in clinical trials for its Gardasil vaccine. Fintan Dunne presents shocking details of Merck’s outrageous alleged fraud and latest analysis of the flaws in the manufacturing of Gardasil and other vaccines including DPT and Hep B.